Tumor dependence on the EGFR signaling pathway expressed by the p-EGFR:p-AKT ratio predicts erlotinib sensitivity in human non-small cell lung cancer (NSCLC) cells expressing wild-type EGFR gene.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples